NASDAQ: CCAPCrescent Capital Bdc Inc Stock
$13.62+0.15 (+1.11%)
Updated May 26, 2023
CCAP Price
$13.62
Fair Value Price
$13.85
Market Cap
$504.78M
52 Week Low
$12.55
52 Week High
$18.20
P/E
64.86x
P/B
0.7x
P/S
3.41x
PEG
N/A
Dividend Yield
12.78%
Revenue
$129.62M
Earnings
$7.11M
Gross Margin
53.8%
Operating Margin
5.64%
Profit Margin
5.5%
Debt to Equity
1.27
Operating Cash Flow
$33M
Beta
0.66
Next Earnings
N/A
Ex-Dividend
Jun 29, 2023
Next Dividend
Jul 17, 2023
CCAP Overview
Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CCAP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CCAP ($13.62) is undervalued by 1.67% relative to our estimate of its Fair Value price of $13.85 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CCAP ($13.62) is not significantly undervalued (1.67%) relative to our estimate of its Fair Value price of $13.85 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CCAP was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CCAP due diligence checks available for Premium users.
Be the first to know about important CCAP news, forecast changes, insider trades & much more!
CCAP News
Valuation
CCAP fair value
Fair Value of CCAP stock based on Discounted Cash Flow (DCF)
Price
$13.62
Fair Value
$13.85
Undervalued by
1.67%
CCAP ($13.62) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CCAP ($13.62) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CCAP was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CCAP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
64.86x
Industry
46.45x
Market
54.23x
CCAP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CCAP is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CCAP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.7x
Industry
1.94x
CCAP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CCAP's financial health
Profit margin
Revenue
$39.3M
Net Income
$7.8M
Profit Margin
19.8%
CCAP's Earnings (EBIT) of $7.31M... subscribe to Premium to read more.
Interest Coverage Financials
CCAP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.6B
Liabilities
$912.7M
Debt to equity
1.27
CCAP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CCAP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$16.0M
Investing
$0.0
Financing
$1.4M
CCAP's operating cash flow ($32.79M)... subscribe to Premium to read more.
Debt Coverage Financials
CCAP vs Asset Management Stocks
Crescent Capital Bdc Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.